For instance, in chronic lymphoid leukemia, patient-derived exosomes have elevated CD19, CD31, CD44, CD82, HLA-A to D, levels, while low levels of CD21, CD49c, and CD63. This evidence concerns the gene CD19 and lymphoid leukemia.